No products in the cart.

No products in the wishlist.

We deliver to:

🇦🇺 Australia

🇧🇪 Belgium

🇨🇦 Canada

🇨🇿 Czechia

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇬🇷 Greece

🇭🇺 Hungary

🇮🇪 Ireland

🇮🇱 Israel

🇮🇹 Italy

🇯🇵 Japan

🇰🇼 Kuwait

🇱🇻 Latvia

🇱🇹 Lithuania

🇲🇽 Mexico

🇲🇩 Moldova

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇷🇴 Romania

🇸🇰 Slovakia

🇰🇷 South Korea

🇨🇭 Switzerland

🇬🇧 United Kingdom

🇺🇸 United States of America

and more

  • Milistan
  • Milistan
Please note: The product packaging may vary from the images shown. The contents, ingredients, and quality of the product remain unchanged.

Milistan Combi nasal Express test for COVID-19 virus antigen and influenza A/B detection 1 pc.

$48.47

*All prices are in US dollars (USD)

Free Worldwide Shipping

to: Australia, Belgium, Canada, Czechia, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Israel, Italy, Japan, Kuwait, Latvia, Lithuania, Mexico, Moldova, Netherlands, Norway, Poland, Romania, Slovakia, South Korea, Switzerland, United Kingdom, United States and more

🏖️ Hello! We are on vacation!

We are still accepting orders on our website; however, order processing and shipping will resume after September 10. If you place an order during our vacation, we will contact you and remind you about the temporary shipping delay. Starting September 10, all orders received during this period will be processed and shipped in the order they were placed. If your order contains a product with less than one year remaining before its expiration date, we will notify you after September 10 and proceed according to your instructions. If you decide to cancel an order placed during our vacation, simply contact us through the contact form on our website, and we will be happy to assist you. Thank you for your understanding, and we apologize for any inconvenience caused.

In stock

Milistan Combi Nasal Test: rapid antigen test for COVID-19 and influenza A/B from a nasal swab. Result in 15 minutes. Kit contents and instructions.

Can’t find it? Ask us via WhatsApp, Telegram, Viber or chat

Payment

PayPal, Debit or Credit card, Google Pay, Apple Pay

or

Orders Temporarily Unavailable

Due to temporary postal service disruptions, we are currently unable to accept orders.

Milistan Combination Nasal Test Express Test for Detection of COVID-19 Virus Antigen and Influenza A/B is an in vitro immunological assay. The assay is intended for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens and influenza A/B in nasal cavity content samples.

Principle of analysis

COVID-19 test:

Anti-SARS-CoV-2 antibodies are immobilized on the test area of ​​a nitrocellulose membrane. Anti-SARS-CoV-2 antibodies conjugated to colored particles are immobilized on a conjugate pad. Nasal secretions collected by the user must be mixed with the extraction buffer, which is individually packaged in the kit.

During testing, the target antigens, if present in the nasal secretions, will be released into the extraction buffer. The sample is transported by capillary action, interacts with the reagents on the sample pad, and then the target antigens will bind to the anti-SARS-CoV-2 antibodies on the conjugate pad. Thus, the antigen-antibody complex will capture the anti-SARS-CoV-2 antibodies immobilized in the test region. Excess colored particles will be captured in the control region of the membrane.

The presence of a colored band in the test zone indicates a positive result for SARS-CoV-2 viral antigens, and its absence indicates a negative result. The colored band in the control zone is intended for the control procedure, it indicates that sufficient sample has been added and the migration of fluid along the membrane has been successful.

Influenza A/B test:

Anti-influenza A and anti-influenza B antibodies are immobilized on two separate test areas of a nitrocellulose membrane. Anti-influenza A and anti-influenza B antibodies conjugated to colored particles are immobilized on a conjugate pad.

Nasal secretions collected by the user must be mixed with the extraction buffer, which is individually packaged in the kit.

During testing, the target antigens, if present in the nasal secretions, will be released into the extraction buffer. The sample moves along the strip by capillary action, it interacts with the reagents on the sample pad, and then the target antigens bind to the antibodies on the conjugate pad. Therefore, the antigen-antibody complex will be captured by the antibodies immobilized on the two test areas. Excess colored particles will be captured in the control area of ​​the membrane.

The presence of a colored band in the test zones indicates a positive result for influenza A and B viral antigens, and its absence indicates a negative result. The colored band in the control zone is intended for the control procedure, it indicates that sufficient specimen has been added and the fluid migration along the membrane has been successful.

Equipment

Materials provided

  • pen for sampling nasal cavity contents with test strips for COV and FLU;
  • extraction buffer;
  • instructions for use.

Required materials that are not provided

  • clock, timer or stopwatch.

Application features

  • for in vitro diagnostic use only;
  • Carefully insert the device into your nostrils;
  • do not swallow;
  • Before starting the test, carefully read the instructions for use to obtain an accurate result. You must follow its instructions;
  • do not use the kit or its components after the expiration date;
  • The device contains animal material and should be handled as a potential biohazard. Do not use if the package is damaged or opened;
  • The test devices are packaged in foil pouches that prevent moisture from entering during storage. Inspect the foil pouch before opening. Do not use the devices if the foil has holes or if the pouch is not completely sealed. Erroneous results may be obtained if reagents or kit components that have been stored improperly are used;
  • Failure to bring specimens and reagents to room temperature prior to testing may reduce assay sensitivity. Inaccurate or improper specimen collection, storage, and transportation may result in false-negative assay results;\
  • avoid skin contact with the buffer;
  • Do not pierce the foil in the extraction buffer container before testing.

Method of application

Test procedure

  1. The test kit must be brought to room temperature (15~30°C) before use.
  2. Remove the nasal swab handle from the packaging, remove the protective cap from the sample collection pad.
  3. Carefully insert the sample collection pad into the nasal passage to a depth of approximately 1 – 2 cm, twist 5 (five) times and remove.
  4. Perform a similar manipulation with the second nasal passage to collect a sufficient amount of sample.
  5. Place the test pen vertically into the extraction buffer container, gently press to break the foil. The edge of the extraction buffer container should align with the top edge of the marking ring on the test device.
  6. Determine the result after 15 minutes.

Importantly

It is necessary to obtain as much sample as possible.

This procedure may cause discomfort. Do not advance the pad further if there is significant resistance. Testing of children 2 to 15 years of age should be performed by an adult.

It is important to ensure that the marking ring on the test device is aligned with the edge of the extraction buffer container. Otherwise, lateral flow will be disrupted and the test result will be invalid.

Result

POSITIVE

For COVID-19 test. COV test strip

  • Two colored lines appear on the membrane. One line appears in the control region (C) and the other line appears in the test region (T).

For influenza A test. FLU test strip

  • One colored line appears in the control region (C). A second line appears in the test region A (at the lower edge).

For influenza B test. FLU test strip

  • One colored line appears in the control region (C). A second line appears in the test region B (inside the membrane).

For testing for influenza A and B. FLU test strip

  • One colored line appears in the control region (C). Two lines appear in the test region.

NEGATIVE

For COVID-19 test. COV test strip

  • Only one colored line appears in the control region (C).
  • No visible colored lines appear in the test region (T).

For testing for influenza A and B. FLU test strip

  • Only one colored line appears in the control region (C).
  • No visible colored bands appear in the test region (B) and (A).

INVALID

Any test result that does not produce a line in the control region after the specified reading time is invalid. Please review the test procedure and repeat it using a new test. If the problem persists, discontinue use of the kit immediately and contact your local distributor.

Performance indicators

Analytical sensitivity:

The limit of detection (LOD) of the Milistan Combination Nasal Test Rapid Test for the Detection of COVID-19 and Influenza A/B Virus Antigen, defined as the concentration of influenza virus and SARS-CoV-2 virus that gives a positive test result, is approximately 95%, as determined by evaluating different concentrations of inactivated influenza A virus (H3N2, H1N1), inactivated influenza B virus (Victoria, Yamagata) and inactivated SARS-CoV-2 virus with the Milistan Comfort Nasal Test Rapid Test for the Detection of COVID-19 and Influenza A/B Virus Antigen. 20 tests were performed for each concentration. The test results determined a concentration of 1.0 × 104 TCID50/mL as the LOD for influenza A (H3N2), 4.3 × 104 TCID50 as the LOD for influenza A (H1N1), 2.2 × 105 TCID50 for influenza B (Victoria), 2.5 × 105 TCID50 for influenza B (Yamagata), and 1 × 102.4 TCID50/mL as the LOD for SARS-CoV-2.

Clinical assessment:

To detect COVID-19 virus antigen:

A total of 197 clinical samples were selected to test the effectiveness of the Milistan Combi Nasal Test Express Test for the detection of COVID-19 and influenza A/B virus antigens compared to RT-PCR testing. No differences in test results were found depending on the age and gender of the patient. 41 samples were detected positive by RT-PCR, and 156 samples were negative by RT-PCR testing. These samples were tested using the Milistan Combi Nasal Test Express Test for the detection of COVID-19 and influenza A/B virus antigens.

Storage conditions

Store the MILISTAN COMFORT nasal test Express test for the detection of COVID-19 virus antigen when not in use at a temperature of 2 ~ 30 °C.

Do not freeze.

The kit components are stable until the expiration date indicated on the packaging.

Reviews

There are no reviews yet.

Be the first to review “Milistan Combi nasal Express test for COVID-19 virus antigen and influenza A/B detection 1 pc.”

Your email address will not be published. Required fields are marked